passa ai contenuti
Systemic Treatment of Prostate Cancer Anteprima di questo documento
ChiudiAnteprima di questo documento
Stiamo controllando…

Systemic Treatment of Prostate Cancer

Autore: Alan Horwich
Editore: Oxford : OUP Oxford, 2010.
Serie: Oxford oncology library.
Edizione/Formato:   eBook : Document : EnglishVedi tutte le edizioni e i formati
Banca dati:WorldCat
Sommario:
Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is  Per saperne di più…
Voto:

(non ancora votato) 0 con commenti - Diventa il primo.

Soggetti
Altri come questo

 

Trova una copia online

Collegamenti a questo documento

Trova una copia in biblioteca

&AllPage.SpinnerRetrieving; Stiamo ricercando le biblioteche che possiedono questo documento…

Dettagli

Genere/forma: Electronic books
Informazioni aggiuntive sul formato: Print version:
Horwich, Alan
Systemic Treatment of Prostate Cancer
Oxford : OUP Oxford, c2010
Tipo materiale: Document, Risorsa internet
Tipo documento: Internet Resource, Computer File
Tutti gli autori / Collaboratori: Alan Horwich
ISBN: 9780191575815 019157581X
Numero OCLC: 763157034
Descrizione: 1 online resource (102 p.)
Contenuti: Biological principles of hormone therapy --
PSA as a marker of progression and response in advanced prostate cancer --
Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer --
Systemic treatment of recurrence after local therapies --
First-line hormone therapy for metastatic prostate cancer --
Second- and third-line hormone therapies --
Chemotherapy for metastatic prostate cancer --
Role of bisphosphonates in the systemic treatment of prostate cancer --
Systemic isotope therapy of bone metastasis --
Biological targets and new drug development for prostate cancer.
Titolo della serie: Oxford oncology library.

Abstract:

Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r.

Commenti

Commenti degli utenti
Recuperando commenti GoodReads…
Stiamo recuperando commenti DOGObooks

Etichette

Diventa il primo.

Documenti simili

Soggetti correlati:(5)

Liste di utenti con questo documento (2)

Conferma questa richiesta

Potresti aver già richiesto questo documento. Seleziona OK se si vuole procedere comunque con questa richiesta.

Dati collegati


<http://www.worldcat.org/oclc/763157034>
library:oclcnum"763157034"
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/763157034>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:creator
schema:datePublished"2010"
schema:description"Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r."@en
schema:description"Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/412274331>
schema:genre"Electronic books."@en
schema:inLanguage"en"
schema:name"Systemic Treatment of Prostate Cancer"@en
schema:publisher
schema:url
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998>
schema:url<http://public.eblib.com/EBLPublic/PublicView.do?ptiID=797725>
schema:url<http://www.myilibrary.com?id=334833>
schema:workExample

Content-negotiable representations

Chiudi finestra

Per favore entra in WorldCat 

Non hai un account? Puoi facilmente crearne uno gratuito.